iShares Genomics Immunolo... (IDNA)
NYSEArca: IDNA
· Real-Time Price · USD
35.42
+0.22 (0.62%)
At close: Aug 12, 2026, 3:54 PM
35.42
+0.00%
After-hours: 5:05 PM
iShares Genomics Immunology and Healthcare ETF (IDNA) ETF Price, Holdings & Analysis
0.62% (1D)
| Bid | 31.73 |
| Market Cap | n/a |
| AUM | 190.86M |
| NAV | 35.21 |
| Beta | 1.12 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 22.76 |
| Shares Out | n/a |
| Inception Date | Jun 11, 2019 |
| Ask | 38.61 |
| Volume | 13,689 |
| Avg. Volume (20D) | 46,074 |
| Open | 35.22 |
| Previous Close | 35.20 |
| Day's Range | 34.85 - 35.42 |
| 52-Week Range | 21.85 - 35.42 |
| Holdings | n/a |
| Expense Ratio | 0.47% |
About IDNA
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-. The fund is non-diversified.
Asset Class Equity
Ticker Symbol IDNA
Inception Date Jun 11, 2019
Provider Ishares
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 43.01% of assets
| Name | Symbol | Weight |
|---|---|---|
| Bayer Ag | BAYN.DE | 4.80% |
| Twist Bioscience Cor... | TWST | 4.80% |
| Revolution Medicines... | RVMD | 4.56% |
| Regeneron Pharmaceut... | REGN | 4.35% |
| Incyte Corp | INCY | 4.23% |
| Genmab As | GMAB.CO | 4.21% |
| Moderna Inc | MRNA | 4.19% |
| Takeda Pharmaceutica... | 4502.T | 4.09% |
| Merck & Co Inc | MRK | 3.91% |
| Vertex Pharmaceutica... | VRTX | 3.87% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 15, 2026 | $0.1250 | n/a |
| Dec 16, 2025 | $0.1550 | n/a |
| Jun 16, 2025 | $0.1530 | n/a |
| Dec 17, 2024 | $0.1110 | n/a |
| Jun 11, 2024 | $0.1110 | n/a |
